Towards Forensic Application of Solid-Phase Microextraction

Total Page:16

File Type:pdf, Size:1020Kb

Load more

TOWARDS FORENSIC APPLICATION OF SOLID-PHASE MICROEXTRACTION Development and validation of an SPME approach to study pharmaceuticals and illicit drugs Hester Peltenburg colofon Towards forensic application of solid-phase microextraction. Development and validation of an SPME approach to study pharmaceuticals and illicit drugs. Copyright © 2016 Hester Peltenburg ISBN/EAN: 978-90-9029292-2 Cover design, layout and printing: proefschrift-aio.nl The research described in this thesis was performed at the Institute for Risk Assessment Sciences, faculty of Veterinary Medicine, Utrecht University. The work was carried out in cooperation with the Netherlands Forensic Institute, department of Forensic Medicine. The prototype C18/SCX fibers used in the research in this thesis were kindly provided by dr. Robert Shirey from Supelco, Sigma Aldrich (Bellafonte, PA, USA). TOWARDS FORENSIC APPLICATION OF SOLID-PHASE MICROEXTRACTION Development and validation of an SPME approach to study pharmaceuticals and illicit drugs “Solid-phase microextraction” als toekomstige bemonsteringstechniek in forensisch onderzoek (met een samenvatting in het Nederlands) Proefschrift ter verkrijging van de graad van doctor aan de Universiteit Utrecht op gezag van de rector magnificus, prof.dr. G.J. van der Zwaan, ingevolge het besluit van het college voor promoties in het openbaar te verdedigen op dinsdag 7 juni 2016 des middags te 12.45 uur door Hester Peltenburg geboren op 12 september 1987 te Utrecht Promotoren: Prof. dr. M. van den Berg Prof. dr. J.L.M. Hermens Copromotoren: Dr. I.J. Bosman Dr. S.T.J. Droge TABLE OF CONTENT 1 7 5 147 Introduction Sensitive determination of plasma protein binding - of cationic drugs using mixed-mode solid-phase microextraction 2 39 - Elucidating the sorption mechanism of “mixed-mode” 187 SPME using the basic drug 6 amphetamine as a model compound Direct tissue sampling of diazepam and amitriptyline - using mixed-mode spme fibers: a feasability study 69 3 - Sorption of amitriptyline and 207 amphetamine to mixed-mode 7 spme in different test conditions General discussion - - 111 4 245 8 Sorption of structurally different pharmaceutical and illicit Summaries drugs to a mixed-mode coated microsampler - - 6 Chapter 1 1 INTRODUCTION 7 BACKGROUND Essential in forensic toxicology is the detection and evaluation of postmortem drug concentrations to determine whether a compound can be identified as the cause of death or a contributor to the cause of death. However, postmortem drug concentrations do not necessarily reflect the concentration at the time of death and vary according to the sampling site and time interval between death and sample collection. A major problem in chemical analysis in forensics studies is that the amount of biological sample is often limited. Moreover, it is not possible to perform repeated sampling after death without disturbance of the biological system. Roughly half of the 57 drugs of abuse that are screened routinely at the Netherlands Forensic Institute are predominantly ionized at physiological pH. Whereas the partition behavior and sampling methodology for neutral toxicants is reasonably well documented, understanding the distribution processes of ionizable compounds and interpreting sampling data poses various scientific challenges. The major aim of this thesis is to develop new analytical techniques that can be applied in postmortem redistribution studies of drugs and pharmaceuticals. To accomplish this, a sampling method using solid-phase microextraction (SPME) was investigated and optimized for a selected number of compounds, specifically focusing on ionizable drugs of abuse. In this chapter, forensic toxicology is introduced. Special attention is given to the uptake, distribution, metabolism and elimination of compounds, and in particular ionizable compounds. These processes are also discussed in the light of a postmortem situation, which leads to the introduction of the phenomenon of postmortem redistribution. Current analytical tools in forensic studies are highlighted, with special attention for solid-phase microextraction. FORENSIC TOXICOLOGY Forensic toxicology is a discipline in toxicology that aids in the legal investigation of death, poisoning or drug use. Most important in this field is the collection of data and the interpretation of the results. At the Netherlands Forensic Institute, most toxicological cases are concerned with driving under the influence of either alcohol or drugs. In 2014, more than 3000 cases were reviewed by the forensic toxicology department (figure 1). While only a small 8 Introduction Chapter 1 Figure 1. Overview of forensic toxicology cases in the Netherlands, as recorded by the Netherlands Forensic Institute. Report year: 2014 Figure 2. Diffusion of charged chemicals is possible across phospholipid membranes (left arrow), epithelium (middle arrow), and basement membrane (right arrow). The numbers indicate the fold increase in permeability of the neutral versus the charged species of an ionizable compound (Avdeef, 2012). Also, the uptake of charged chemicals can be altered by the presence of a pH microclimate and differences in intracellular pH. 9 portion of the total number of cases concerned forensic autopsies and their outcome, the complexity of postmortem toxicology makes it a large part of the work of a forensic toxicologist. Postmortem toxicology The interpretation of toxicological results is mostly based on pharmacokinetic and pharmacodynamic data. In clinical toxicology, or antemortem, this data on concentration-effect relations is readily available. For pharmaceuticals, the deposition of the compound within the body is well studied. Deposition is defined by a number of processes, including absorption, distribution, metabolism and elimination (ADME in short). In a postmortem situation, changes can occur in these processes. The following paragraphs describe the ADME processes, with potential postmortem changes. Absorption Absorption describes the uptake of the compound into the bloodstream and, together with metabolism, determines the bioavailability. The route of administration is an important consideration in absorption. Most pharmaceuticals are administered orally, and need to be taken up from the gastrointestinal tract. The uptake is mainly driven by passive diffusion, and requires ionizable compounds to be in their neutral form. This is also known as the pH partitioning hypothesis (Avdeef 2012). The uptake of ionizable compounds is therefore dependent on the pH inside the gastrointestinal tract. Due to the large pH gradient in the gastrointestinal tract the uptake of ionizable chemicals is highly location-specific. Uptake of anionic compounds mostly occurs in the stomach, whereas cationic compounds are taken up in the colon (Avdeef 2012). However, there are some exceptions to the pH partitioning hypothesis, which allow for the diffusion of the charged form of a compound (figure 2). First of all, passive diffusion is not solely reserved to the neutral form of a chemical. The charged species of a compound is capable of passive diffusion, albeit at much lower rates than for the neutral species. Figure 2 shows the fold increase in permeability of the neutral form of a chemical over the charged form over different intestinal barriers Avdeef( 2012). The permeability of the neutral form of a chemical is 108 greater than for the charged form for the transport across a phospholipid bilayer. For the epithelium itself, this factor is 105, in part due to paracellular transport and ion-selectivity in the tight 10 Introduction junctions. For the basement membrane, ion-selectivity reduces the difference Chapter 1 between neutral and ionized permeability to a factor 10. Secondly, the pH close to the epithelium might be different than the pH in the lumen itself. The microclimate pH in the intestine can be up to two log units lower than the luminal pH, most likely created by the amphoteric nature of the mucus layer (Shiau et al. 1985). In the stomach, reported microclimate pH is 8.0, whereas the normal pH of the stomach is 1.7 in fasted condition (Rechkemmer 1991). Here, the secretion of HCO3- from the gastric epithelium greatly influences the microclimate pH (Rechkemmer 1991). Lastly, intracellular pH also affects absorption. Within a cell, pH can be as low as 4.5 in lysosomes and as high as 8.0 in mitochondria (Asokan & Cho 2002). This can have a dramatic effect on charge and physicochemical properties of weak acids and bases. Specifically, ionizable compounds can enter the cell as a neutral compound, but become charged inside the cell due to the difference in intracellular pH. In its charged form, the compound cannot diffuse as effectively out of the cell, leading to accumulation inside the cell. This is known as ion trapping. In forensic toxicology, one should be aware that illicit drugs usually have a different or unconventional route of administration compared to pharmaceutical drugs. Examples of these types of administration routes include smoking, snorting and self-injecting drugs. The route of administration can affect uptake, blood concentration and rate of metabolism, thereby affecting total body disposition Drummer( 2007). Postmortem, passive diffusion continues, and so does absorption. An example of this is after an overdose of an orally ingested drug. Death might occur before absorption is complete, leading to higher concentrations in blood and tissue near the stomach than elsewhere in the body, due to ongoing absorption (Ferner 2008). Other factors
Recommended publications
  • ECO-Ssls for Pahs

    ECO-Ssls for Pahs

    Ecological Soil Screening Levels for Polycyclic Aromatic Hydrocarbons (PAHs) Interim Final OSWER Directive 9285.7-78 U.S. Environmental Protection Agency Office of Solid Waste and Emergency Response 1200 Pennsylvania Avenue, N.W. Washington, DC 20460 June 2007 This page intentionally left blank TABLE OF CONTENTS 1.0 INTRODUCTION .......................................................1 2.0 SUMMARY OF ECO-SSLs FOR PAHs......................................1 3.0 ECO-SSL FOR TERRESTRIAL PLANTS....................................4 5.0 ECO-SSL FOR AVIAN WILDLIFE.........................................8 6.0 ECO-SSL FOR MAMMALIAN WILDLIFE..................................8 6.1 Mammalian TRV ...................................................8 6.2 Estimation of Dose and Calculation of the Eco-SSL ........................9 7.0 REFERENCES .........................................................16 7.1 General PAH References ............................................16 7.2 References Used for Derivation of Plant and Soil Invertebrate Eco-SSLs ......17 7.3 References Rejected for Use in Derivation of Plant and Soil Invertebrate Eco-SSLs ...............................................................18 7.4 References Used in Derivation of Wildlife TRVs .........................25 7.5 References Rejected for Use in Derivation of Wildlife TRV ................28 i LIST OF TABLES Table 2.1 PAH Eco-SSLs (mg/kg dry weight in soil) ..............................4 Table 3.1 Plant Toxicity Data - PAHs ..........................................5 Table 4.1
  • OECD Environment Health and Safety Publications Series on Testing and Assessment No

    OECD Environment Health and Safety Publications Series on Testing and Assessment No

    OECD Environment Health and Safety Publications Series on Testing and Assessment No. 21 Detailed Review Paper Appraisal of Test Methods for Sex Hormone Disrupting Chemicals Environment Directorate ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT Paris May 2001 1 Also Published in the Series Testing and Assessment: No. 1, Guidance Document for the Development of OECD Guidelines for Testing of Chemicals (1993; reformatted 1995) No. 2, Detailed Review Paper on Biodegradability Testing (1995) No. 3, Guidance Document for Aquatic Effects Assessment (1995) No. 4, Report of the OECD Workshop on Environmental Hazard/Risk Assessment (1995) No. 5, Report of the SETAC/OECD Workshop on Avian Toxicity Testing (1996) No. 6, Report of the Final Ring-test of the Daphnia magna Reproduction Test (1997) No. 7, Guidance Document on Direct Phototransformation of Chemicals in Water (1997) No. 8, Report of the OECD Workshop on Sharing Information about New Industrial Chemicals Assessment (1997) No. 9 Guidance Document for the Conduct of Studies of Occupational Exposure to Pesticides During Agricultural Application (1997) No. 10, Report of the OECD Workshop on Statistical Analysis of Aquatic Toxicity Data (1998) No. 11, Detailed Review Paper on Aquatic Testing Methods for Pesticides and industrial Chemicals (1998) No. 12, Detailed Review Document on Classification Systems for Germ Cell Mutagenicity in OECD Member Countries (1998) No. 13, Detailed Review Document on Classification Systems for Sensitising Substances in OECD Member Countries 1998) No. 14, Detailed Review Document on Classification Systems for Eye Irritation/Corrosion in OECD Member Countries (1998) No. 15, Detailed Review Document on Classification Systems for Reproductive Toxicity in OECD Member Countries (1998) No.
  • Effect of Surfactant–Bile Interactions on the Solubility of Hydrophobic

    Effect of Surfactant–Bile Interactions on the Solubility of Hydrophobic

    Article Cite This: Mol. Pharmaceutics 2018, 15, 5741−5753 pubs.acs.org/molecularpharmaceutics Effect of Surfactant−Bile Interactions on the Solubility of Hydrophobic Drugs in Biorelevant Dissolution Media Zahari Vinarov,*,† Vladimir Katev,† Nikola Burdzhiev,‡ Slavka Tcholakova,† and Nikolai Denkov† † Department of Chemical and Pharmaceutical Engineering, Faculty of Chemistry and Pharmacy, Sofia University, 1164 Sofia, Bulgaria ‡ Department of Organic Chemistry and Pharmacognosy, Faculty of Chemistry and Pharmacy, Sofia University, 1164 Sofia, Bulgaria *S Supporting Information ABSTRACT: Biorelevant dissolution media (BDM) methods are commonly employed to investigate the oral absorption of poorly water-soluble drugs. Despite the significant progress in this area, the effect of commonly employed pharmaceutical excipients, such as surfactants, on the solubility of drugs in BDM has not been characterized in detail. The aim of this study is to clarify the impact of surfactant−bile interactions on drug solubility by using a set of 12 surfactants, 3 model hydrophobic drugs (fenofibrate, danazol, and progesterone) and two types of BDM (porcine bile extract and sodium taurodeoxycholate). Drug precipitation and sharp nonlinear decrease in the solubility of all studied drugs is observed when drug-loaded ionic surfactant micelles are introduced in solutions of both BDM, whereas the drugs remain solubilized in the mixtures of nonionic polysorbate surfactants + BDM. One-dimensional and diffusion-ordered 1H NMR spectroscopy show that mixed bile salt + surfactant micelles with low drug solubilization capacity are formed for the ionic surfactants. On the other hand, separate surfactant-rich and bile salt-rich micelles coexist in the nonionic polysorbate surfactant + bile salt mixtures, explaining the better drug solubility in these systems.
  • (12) Patent Application Publication (10) Pub. No.: US 2008/0299054 A1 Chandar Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2008/0299054 A1 Chandar Et Al

    US 20080299054A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2008/0299054 A1 Chandar et al. (43) Pub. Date: Dec. 4, 2008 (54) PERSONAL CARE COMPOSITIONS WITH Publication Classification ENHANCED FRAGRANCE DELVERY (51) Int. Cl. (75) Inventors: Prem Chandar, Closter, NJ (US); A6IR 8/34 (2006.01) Lin Yang, Woodbridge, CT (US) A6II 3/14 (2006.01) A6II 3/17 (2006.01) Correspondence Address: UNILEVER PATENT GROUP (52) U.S. Cl. .............. 424/54; 424/59: 424/65; 424/70.1; 800 SYLVANAVENUE, AG West S. Wing 514/588 ENGLEWOOD CLIFFS, NJ 07632-3100 (US) (57) ABSTRACT (73) Assignee: CONOPCO, INC., d/b/a UNILEVER, Englewood Cliffs, NJ A personal care product is provided which includes a fra (US) grance, a Substituted urea and a quaternary ammonium salt. The Substituted urea and quaternary ammonium salt operate (21) Appl. No.: 11/755,009 together as a scent boosting system to enhance Volatilization offragrance components upon the personal care composition (22) Filed: May 30, 2007 being first applied to human skin or hair. US 2008/0299054 A1 Dec. 4, 2008 PERSONAL CARE COMPOSITIONS WITH structure AB, wherein A is a cationic charged compo ENHANCED FRAGRANCE DELVERY nent of the salt AB, B is an anionic charged component of the salt AB, and BACKGROUND OF THE INVENTION 0013 A has a single quaternized nitrogen atom, at least two hydroxy groups and a molecular weight no 0001 1. Field of the Invention higher than about 250. 0002 The invention concerns personal care compositions which upon application to a human body Surface quickly release fragrance components thereby improving aesthetics DETAILED DESCRIPTION OF THE INVENTION of these compositions.
  • Biodegradation of Linear Alkylbenzene Sulfonates

    Biodegradation of Linear Alkylbenzene Sulfonates

    BIODEGRADATION OF LINEAR ALKYLBENZENE SULFONATES Applicable to these current Stepan products: BIO-SOFT® D-40 BIO-SOFT® N-300 BIO-SOFT® N-411 BIO-SOFT® S-101 BIO-SOFT® S-101 LS BIO-SOFT® S-111 H BIO-SOFT® S-118 BIO-SOFT® S-120 NACCONOL® 40G NACCONOL® 90G POLYSTEP® A-15 POLYSTEP® A-15-30K STEPWET® DF-90 STEPANTAN® DT-60 BIO-SOFT® D-62 LT BIO-SOFT® L2P-123 POLYSTEP®A-15F Applicable to these inactive Stepan products: BIO-SOFT® D-53 BIO-SOFT® S-100 BIO-SOFT® S-130 POLYSTEP® A-13 POLYSTEP® A-4 POLYSTEP® A-7 STEPANTAN® DS-40 Biodegradation Information: Since their introduction in 1965, linear alkylbenzene sulfonates (LAS) have been used throughout the world as the main anionic surfactant in both household and industrial detergent products. As a result of their wide spread use, the biodegradation characteristics of LAS have been studied thoroughly under both laboratory and environmental conditions. Laboratory tests typically show that LAS will undergo rapid primary and ultimate biodegradation. Due to its favorable biodegradation characteristics, LAS is presently listed as a recommended control substance in the OECD "Readily Biodegradability: Closed Bottle Test". OECD Modified Sturm testing of a LAS product, BIO-SOFT® S-100, showed this product to be readily biodegradable. Primary biodegradation, which can reach 100% in 3 days, involves oxidation of the carbon atoms at the alkyl side chain to form transient, low toxicity sulfophenyl carboxylate intermediates. This is followed by complete breakdown characterized by cleavage of the aromatic ring and total mineralization to carbon dioxide, water and inorganic sulfonates.
  • (12) United States Patent (10) Patent No.: US 8.470,756 B2 O’Brien (45) Date of Patent: Jun

    (12) United States Patent (10) Patent No.: US 8.470,756 B2 O’Brien (45) Date of Patent: Jun

    USOO8470756B2 (12) United States Patent (10) Patent No.: US 8.470,756 B2 O’Brien (45) Date of Patent: Jun. 25, 2013 (54) ECO-FRIENDLY LAUNDRY 6,995,127 B1 2/2006 Smith et al. PRETREATMENT COMPOSITIONS 7,077,870 B2 7/2006 Findlay et al. 7,250,174 B2 7/2007 Lee et al. 7,452,917 B2 11/2008 Baumoeller et al. (75) Inventor: Jeanne A. O’Brien, Racine, WI (US) 7,608,573 B1 10/2009 Scheuing et al. 7,618.931 B1 1 1/2009 Scheuing et al. (73) Assignee: S.C. Johnson & Son, Inc., Racine, WI 2002/0028755 A1* 3/2002 Van Dijk et al. .............. 510,392 2003, OO13629 A1 1/2003 Kischkelet al. (US) 2003/0027736 A1 2/2003 Raths et al. 2003/O122101 A1 7/2003 Prozzo et al. (*) Notice: Subject to any disclaimer, the term of this 2006.0053566 A1 3/2006 Prozzo et al. patent is extended or adjusted under 35 2006/010.5937 A1 5, 2006 Duran U.S.C. 154(b) by 312 days. 2007, OO 10416 A1 1, 2007 Wu et al. 2007/0179074 A1 8, 2007 Souter et al. 2007/O1968.98 A1 8, 2007 Nielsen et al. (21) Appl. No.: 12/405,862 2007/0275021 A1 11/2007 Lee et al. 2008/0000032 A1 1/2008 Wieprecht et al. (22) Filed: Mar 17, 2009 2008.0171683 A1 7/2008 Johnson et al. 2008/O187958 A1 8, 2008 Nielsen et al. (65) Prior Publication Data 2008. O194453 A1 8/2008 Lang 2009.0054294 A1 2/2009 Theiler US 2010/O144580 A1 Jun.
  • Personal Care Compositions with Silicones And

    Personal Care Compositions with Silicones And

    (19) & (11) EP 1 804 922 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61Q 19/00 (2006.01) A61Q 1/02 (2006.01) 13.02.2008 Bulletin 2008/07 A61Q 19/10 (2006.01) A61Q 5/02 (2006.01) A61Q 5/12 (2006.01) A61Q 15/00 (2006.01) (2006.01) (2006.01) (21) Application number: 05797352.1 A61Q 11/00 A61K 8/896 A61K 8/891 (2006.01) A61K 8/58 (2006.01) A61K 8/898 (2006.01) A61K 8/41 (2006.01) (22) Date of filing: 24.10.2005 (86) International application number: PCT/EP2005/011416 (87) International publication number: WO 2006/045583 (04.05.2006 Gazette 2006/18) (54) PERSONAL CARE COMPOSITIONS WITH SILICONES AND DIHYDROXYPROPYL TRIALKYL AMMONIUM SALTS KÖRPERPFLEGEZUSAMMENSETZUNGEN MIT SILIKONEN UND DIHYDROXYPROPYL- TRIALKYL-AMMONIUMSALZEN COMPOSITIONS DE SOINS PERSONNELS COMPRENANT DES COMPOSES SILICONES ET DES SELS DE DIHYDROXYPROPYL TRIALKYL AMMONIUM (84) Designated Contracting States: • MINER, Philip E. AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Unilever Home&Personal Care USA HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI Trumbull, CT 06611 (US) SK TR • BARROW, Stephen Unilever Home&Personal Care USA (30) Priority: 25.10.2004 US 972483 Trumbull, CT 06611 (US) 08.09.2005 US 222189 • CHANDAR, Prem Unilever Home&Personal Care USA (43) Date of publication of application: Trumbull, CT 06611 (US) 11.07.2007 Bulletin 2007/28 • MCMANUS, Richard Unilever Home&Personal Care USA (73) Proprietors: Trumbull, CT 06611 (US) • UNILEVER PLC • HARICHIAN, Bijan London, Greater London EC4P 4BQ (GB) Unilever T.
  • Linear Alkylbenzene Sulfonate (Las)

    Linear Alkylbenzene Sulfonate (Las)

    OECD SIDS LINEAR ALKYLBENZENE SULFONATE (LAS) FOREWORD INTRODUCITON LINEAR ALKYLBENZENE SULFONATE (LAS) 1322-98-1 Decylbenzene sulfonic acid, sodium salt 25155-30-0 Dodecylbenzene sulfonic acid, sodium salt 26248-24-8 Tridecylbenzene sulfonic acid, sodium salt 27636-75-5 Undecylbenzene sulfonic acid, sodium salt 68081-81-2 C10-16 Monoalkylbenzene sulfonic acid, sodium salt 68411-30-3 C10-13 Alkylbenzene sulfonic acid, sodium salt 69669-44-9 C10-14 Alkyl deriv benzene sulfonic acid, sodium salt 85117-50-6 C10-14 Monoalkylbenzene sulfonic acid, sodium salt 90194-45-9 C10-13 Alkyl deriv benzene sulfonic acid, sodium salt 127184-52-5 4-C 10-13-sec Alkyl deriv benzene sulfonic acid, sodium salt UNEP PUBLICATIONS 1 OECD SIDS LINEAR ALKYLBENZENE SULFONATE (LAS) SIDS INITIAL ASSESSMENT REPORT For 20th SIAM Paris, France, 19-21 April, 2005 1. Chemical Name: Linear Alkylbenzene Sulfonate (LAS) 2. CAS Numbers: 1322-98-1 Decylbenzene sulfonic acid, sodium salt 25155-30-0 Dodecylbenzene sulfonic acid, sodium salt 26248-24-8 Tridecylbenzene sulfonic acid, sodium salt 27636-75-5 Undecylbenzene sulfonic acid, sodium salt 68081-81-2 C10-16 Monoalkylbenzene sulfonic acid, sodium salt 68411-30-3 C10-13 Alkylbenzene sulfonic acid, sodium salt 69669-44-9 C10-14 Alkyl deriv benzene sulfonic acid, sodium salt 85117-50-6 C10-14 Monoalkylbenzene sulfonic acid, sodium salt 90194-45-9 C10-13 Alkyl deriv benzene sulfonic acid, sodium salt 127184-52-5 4-C10-13-sec Alkyl deriv benzene sulfonic acid, sodium salt 3. Sponsor Country: United States National SIDS Contact Point in Sponsor Country: Oscar Hernandez, Director U.S.
  • Chemical Study on Alkylphenols

    Chemical Study on Alkylphenols

    Ministerie van Verkeer en Waterstaat Directoraat-Generaal Rijkswaterstaat Rijksinstituut voor Kust en Zee/RIKZ Chemical study on alkylphenols Report: RIKZ/2001.029 1 juli 2001 Authors: BKH Consulting Engineers drs. C.P. Groshart drs. P.C. Okkerman drs. W.B.A. Wassenberg RIKZ drs. A.M.C.M. Pijnenburg BKH Consulting Engineers P.O. Box 5094 2600 GB Delft Tel. 31 15 2625299 Fax 31 15 1619326 RIKZ Kortenaerkade 1 P.O. Box 20907 2500 EX Den Haag Tel. 31 70 3114311 Fax 31 70 3114330 _____________________________________ Chemical study on alkylphenols 1 _____________________________________ Chemical study on alkylphenols 2 Contents . .. Preface 5 Summary 6 1 Introduction 13 1.1 Backgrounds 13 1.2 Objectives 13 1.3 Limitations 14 2 Physical chemical properties 15 2.1 Identification 15 2.1.1 Octylphenols 15 2.1.2 Nonylphenols 16 2.1.3 Alkylphenolethoxylates 17 2.2 Physico-chemical characterisation 17 2.3 References 19 3 Production and use 21 3.1 General 21 3.2 Major producers 21 3.2.1 Alkylphenols 21 3.2.2 Nonylphenol ethoxylates 22 3.3 Production processes 23 3.3.1 Nonylphenol 23 3.3.2 Nonylphenol ethoxylates 24 3.4 Major applications 24 3.4.1 Nonylphenol 24 3.4.2 Nonylphenol ethoxylates 25 3.5 Demands in the EU 28 3.5.1 Nonylphenol 28 3.5.2 Nonylphenol ethoxylates 28 3.6 Demands in the Netherlands 31 3.6.1 Nonylphenol 31 3.6.2 Nonylphenol ethoxylates 32 3.7 Waste disposal 33 3.7.1 Nonylphenol 33 3.7.2 Nonylphenol ethoxylates 34 3.8 Potential alternatives 34 3.8.1 Nonylphenol 34 3.8.2 Nonylphenol ethoxylates 34 3.9 Conclusions and recommendations
  • Critical Literature Review of Analytical Methods Applicable To

    Critical Literature Review of Analytical Methods Applicable To

    FINAL REPORT Reference: PFA.750.011.001 Date: February 2021 Critical literature review of analytical methods applicable to environmental fate studies Critical literature review of analytical methods applicable to environmental fate studies Report number: PFA. 750.011.001 NOTICE This report was commissioned by the European Chemicals Agency (ECHA). The author of the report, Peter Fisk Associates Limited, accepts no liability for loss or damage resulting from reliance on the contents of this report by any third party. This report does not necessarily reflect the official opinion of ECHA or the European Commission. ECHA and the European Commission do not guarantee the accuracy or correctness of the information included in this report. Neither ECHA or the European Commission, nor any person acting on their behalf, may be held responsible or liable for any reliance or use of the information contained in this report. Wood environment and infrastructure solutions UK Client limited (for ECHA under Framework ECHA/2015/50) Client’s reference ECHA/2019/236 This report is issued by Peter Fisk Associates Limited, Saxon House, John Roberts Business Park, Pean Hill, Whitstable, Kent CT5 3BJ. Company Number 05758319. Tel. +44 1227 470901, web www.pfagroup.eu AUTHORISATION RECORD Conclusions drawn and recommendations made in this report represent the unbiased view of Peter Fisk Associates Limited on the basis of the data presented and obtained. The name below confirms that this version of the report is complete and final. Name Oliver Warwick Director Position Peter Fisk Associates Limited Date 11 February 2021 Peter Fisk Associates Limited operates a business management system certified to ISO 9001, 14001 and 27001 for the provision of consultancy services to international clients on the assessment and management of the exposure, hazards and risks of industrial, professional and consumer products in the EU and UK regulatory context.
  • (12) United States Patent (10) Patent No.: US 6,884,842 B2 Soane Et Al

    (12) United States Patent (10) Patent No.: US 6,884,842 B2 Soane Et Al

    USOO6884.842B2 (12) United States Patent (10) Patent No.: US 6,884,842 B2 Soane et al. (45) Date of Patent: Apr. 26, 2005 (54) MOLECULAR COMPOUNDS HAVING 5,630,978 A 5/1997 Domb COMPLEMENTARY SURFACESTO 5,663,387 A 9/1997 Singh TARGETS 5,728.296 A 3/1998 Hjerten et al. 5,814.223 A 9/1998 Hjerten et al. (75) Inventors: David S. Soane, Piedmont, CA (US); 5,834,0255,821,311. A 11/199810/1998 deMosbach Garavilla et al.et al. Stephen E. Barry, Oakland, CA (US); 5858.2962Y- a-2 A 1. f1999 Domb Andrew Goodwin, Oakland, CA (US); 5,872,198. A 2/1999 Mosbach et al. David A. Offord, Castro Valley, CA 5,914,367 A 6/1999 Dordick et al. (US); Michael G. Perrott, San 5,916,445 A 6/1999 Hjerten et al. Francisco, CA (US) 5,916,596 A 6/1999 Desai et al. 5,959,050 A 9/1999 Mosbach et al. (73) Assignee: Alnis BioSciences, Inc., Emeryville, 5,994,110 A 11/1999 Mosbach et al. CA (US) 6,051,372 A 4/2000 Bayerl et al. 6,127,154 A 10/2000 Mosbach et al. (*) Notice: Subject to any disclaimer, the term of this 6,177,513 B1 1/2001 Takeuchi et al. patent is extended or adjusted under 35 6.217.901 B1 4/2001 Perrott et al. U.S.C. 154(b) by 179 days. FOREIGN PATENT DOCUMENTS DE 19627 162 C1 8/1997 (21) Appl. No.: 10/055,837 DE 198 23432 A1 3/1999 (22) Filed: Oct.
  • EAS Abstracts 2015.Indd

    EAS Abstracts 2015.Indd

    EAS.org ABSTRACT BOOK 2015 Eastern Analytical Symposium & Exposition ANALYTICAL INNOVATION FROM BENCHTOP TO BUSINESS Garden State Exhibit Center | Somerset, NJ November 16–18, 2015 Analytical eas.org Chemistry Opens Doors 2016 EASTERN ANALYTICAL SYMPOSIUM & EXPOSITION SAVE THE DATE November 14–16, 2016 Garden State Exhibit Center Somerset, NJ Three-day technical program State-of-the-art exposition featuring analytical equipment and services Extensive selection of short courses and professional development workshops Employment bureau, and more 001646-EAS_8.5x11_IFC_v3.indd 1 11/2/15 12:13 PM Analytical Chemistry Opens Doors 2016 EASTERN ANALYTICAL SYMPOSIUM & EXPOSITION eas.org Garden State Exhibit Center Somerset, NJ November 14–16, 2016 Call for Papers March 5–May 16, 2016 Abstracts received from May 16–Sept 12, 2016, will be reviewed for quality to be included in the poster session. You will be notified via email when/if the abstract is placed. EAS seeks contributed abstracts in these and other analytical fields: Bioanalysis Microscopy Capillary Electrophoresis Nanoparticles Chemometrics Near-Infrared (NIR) Spectroscopy Conservation Science NMR Spectroscopy Environmental Analysis Pharmaceutical Analysis ESR Spectroscopy Process Analytical Science Food Analysis Protein Analysis Forensic Analysis Quality-by-design Gas Chromatography Quality/Regulatory/Compliance HPLC Raman Spectroscopy ICP/MS Sample Preparation Immunochemistry Science Education Industrial Hygiene Sensors Ion Chromatography Size Exclusion